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Abstract
Background: There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the
tropical African outpatient setting.
Methods: We studied a systematic sample of children aged ,5 years presenting to a rural district hospital in Kenya with
acute respiratory infection (ARI) between May 2002 and April 2004. We collected clinical data and screened nasal wash
samples for RSV antigen by immunofluorescence. We used a linked demographic surveillance system to estimate disease
incidence.
Results: Among 2143 children tested, 166 (8%) were RSV positive (6% among children with upper respiratory tract infection
and 12% among children with lower respiratory tract infection (LRTI). RSV was more likely in LRTI than URTI (p,0.001). 51%
of RSV cases were aged 1 year or over. RSV cases represented 3.4% of hospital outpatient presentations. Relative to RSV
negative cases, RSV positive cases were more likely to have crackles (RR = 1.63; 95% CI 1.34–1.97), nasal flaring (RR = 2.66;
95% CI 1.40–5.04), in-drawing (RR = 2.24; 95% CI 1.47–3.40), fast breathing for age (RR = 1.34; 95% CI 1.03–1.75) and fever
(RR = 1.54; 95% CI 1.33–1.80). The estimated incidence of RSV-ARI and RSV-LRTI, per 100,000 child years, among those aged
,5 years was 767 and 283, respectively.
Conclusion: The burden of childhood RSV-associated URTI and LRTI presenting to outpatients in this setting is considerable.
The clinical features of cases associated with an RSV infection were more severe than cases without an RSV diagnosis.
Citation: Okiro EA, Ngama M, Bett A, Nokes DJ (2012) The Incidence and Clinical Burden of Respiratory Syncytial Virus Disease Identified through Hospital
Outpatient Presentations in Kenyan Children. PLoS ONE 7(12): e52520. doi:10.1371/journal.pone.0052520
Editor: Benjamin J. Cowling, University of Hong Kong, Hong Kong
Received October 12, 2012; Accepted November 15, 2012; Published December 26, 2012
Copyright:  2012 Okiro et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Financial support was provided by the Wellcome Trust(061584). EAO is supported by the Wellcome Trust under their Research Training Fellowship
programme (#086166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: eokiro@nairobi.kemri-wellcome.org
Introduction
In the developing world pneumonia represents the major public
health disease burden [1,2,3]. Respiratory syncytial virus (RSV) is
the main viral cause of severe pneumonia and bronchiolitis in
infants and young children contributing considerably to the
burden on health services [4,5,6]. Accordingly, the development of
a vaccine for RSV is viewed as a priority [7,8,9].
Most of the information that is available on the clinical
characteristics and epidemiology of RSV is derived from studies of
paediatric patients admitted to hospital with severe respiratory
illness. These data do not present the full extent of the health
burden in the community since they exclude children with disease
not severe enough to require hospital admission, which nonethe-
less has social, morbid and economic costs [10]. Such data are
important in support of estimates of the effectiveness and costs
associated with vaccine intervention.
This gap in our understanding of the RSV disease burden could
be filled using data from outpatient facilities. However, few studies
of RSV have been undertaken in outpatients [11,12], and fewer
still in the developing world [13]. Thus the burden of RSV-acute
respiratory infections (RSV-ARI) in outpatient presentations in
developing countries remains largely un-quantified [10,14], and
this increases the inaccuracy of assessment of its public health
importance.
To fill this gap we undertook continuous surveillance for RSV
disease in children who presented with acute respiratory infection
(ARI) to Kilifi District Hospital (KDH) over a two-year period.
Patients were linked to the population register of the Kilifi Health
and Demographic Surveillance System (KHDSS) to estimate
incidence. This study took place within the context of other studies
on RSV in the same area [10,14,15,16,17,18,19,20,21,22,23].
Methods
Ethics Statement
Ethical clearance for this study was obtained from the Kenyan
National Ethics Review Board and from Coventry Research
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Ethics Committee, UK and signed consent was obtained from the
parent/guardian of every child in the study.
The study was undertaken at the outpatient department of
KDH. The hospital is situated in Kilifi Town in Kilifi District
a rural coastal town in Kenya, and has a major outpatient facility
with around 15,000 paediatric presentations annually. Kilifi
District covers an area of 4,779 km2 with a density of 114
persons/km2 and experiences a tropical climate with seasonal
rainfall (March to July and October to December). Malaria is
endemic with seasonal transmission following the rains [24]. In
2003, the projected district population was 614,106 [25]. Farmers
dependent on agriculture make up 80% of the district population
[26] and are largely of the Mijikenda ethic origin. The population
had a growth rate of 3.1% per annum in 1999 with 18% under the
age of 5 years [25].
Kilifi Health and Demographic Surveillance System (KHDSS)
is a system of continuous surveillance for vital events and
migration in an area of 891 km2 immediately surrounding Kilifi
District Hospital. It was established in 2000 and is maintained by
household visits approximately 3 times per year. In order to
accurately estimate the incidence of ARI and of these the RSV
cases, from May 2003 we determined the residency status within
the KHDSS of all children recruited into the present study. Each
outpatient record from the study population was matched to an
enumeration record from the census to identify residency status at
the time of recruitment. On this basis children were classified as
either resident or non-resident within the KHDSS.
The study was carried out between the first week of May 2002
and the last week of April 2004. The KEMRI Wellcome Trust
Research Programme manages a research clinic adjacent to the
KDH outpatient department, with well-trained clinical officers
and supported by haematology and virology laboratories. Each
weekday morning a trained study field worker (FW) interviewed
mothers presenting with children to the outpatient department of
KDH. Children aged ,5 years who had clinical signs of ARI were
eligible for inclusion in the study. The FW recruited children in
order of attendance aiming to meet a weekly target defined as the
number of inpatient ARI admissions from the preceding week.
ARI was defined as at least one of: (i) runny/blocked nose; (ii)
cough and fever; (iii) difficulty in breathing or; (iv) cough with fast
breathing.
Before each child was seen by a study clinical officer (CO)
details on location of residence were first determined following
which measurements were made of oxygen saturation (pulse
oximetry, NellcorH), weight, heart and respiratory rates, and
axillary temperature on a standard proforma. Each child was then
examined by a study CO who recorded the clinical history and
examination on the standard proforma and made the decision to
request for a nasal wash sample. Among children with an axillary
temperature $37.5uC, or with a history of fever in the previous
week, a blood slide was taken to diagnose malaria (by Giemsa
staining). Nasal wash specimens were examined for RSV antigen
using a direct immunofluorescence test (DFA; Chemicon). Details
of specimen collection and laboratory processing are reported
elsewhere [14].
We categorized ARI cases into lower respiratory tract infections
(LRTI) and upper respiratory tract infections (URTI). LRTI was
defined as acute cough or difficulty in breathing in association with
one or more of the following: (1) increased breathing rate for age,
(2) lower chest wall indrawing, or (3) inability to feed or reduced
consciousness or level or hypoxia (O2 saturation ,90%), with
severe LRTI defined as either 2 or 3 as previously described [14].
URTI was defined as acute cough or difficulty in breathing or
nasal congestion/discharge, without further signs of severe re-
spiratory disease.
The target population was the total population of children less
than 5 years presenting to KDH outpatient department with ARI
during the study period. To characterize the target population, we
extracted all the information of visits made during the study period
from KDH outpatient registers. In this population a clinical
diagnosis was ascribed by the Government clinician and this was
recorded in the patient registers. However, information on patient
specific symptoms is not routinely recorded in the outpatient
register and is usually recorded in the patient record books which
are retained by the guardians and were therefore not available.
Thus diagnoses among children who were not included in the
RSV study were made without reference to the study criteria and
we relied on the diagnoses of URTI or LRTI made by the
clinicians in the KDH outpatient department. We defined the
target population as the total population presenting to KDH
outpatient department with a respiratory infection and those
selected for the study are referred to as the study population.
The Meteorological data used in this study was collected at the
Kilifi Agricultural Institute located less than 2 kilometers away
from KDH. Daily data on rainfall, relative humidity and
maximum and minimum temperatures was available for the
whole study period. For each month we computed the total
monthly precipitation (mm), relative humidity (RH), and average
maximum and minimum temperatures.
Data Analysis
Statistical analysis was undertaken using Stata version 11.0
(StataCorp LP, TX USA) and Microsoft Excel 2007. The pattern
of presentations to hospital with RSV-associated infection or
disease was determined among children presenting between May
2002 and April 2004. Because residency status within KHDSS was
only obtained from May 2003 onwards we restricted the analysis
of incidence to May 2003–April 2004. A comparison of age, sex,
and severity distributions of the study sample with the target
population was done using chi square tests.
The following three factors have a possible bearing on incidence
estimation in this study. First, residency status within KHDSS is
not routinely recorded for outpatient department presentations.
Second, LRTI definitions used by the outpatient department were
not those applied to the study sample. Third, the study sample
differed from the outpatient department in the proportion of
infants. To account for these factors, the number of ARI
presentations to the outpatient department was scaled by the
proportion of the study sample identified as KHDSS resident
(66.18%), the number of LRTI presentations to the outpatient
department was estimated as the number of KHDSS resident ARI
cases scaled by the proportion of children in the study population
diagnosed as LRTI, and the scaling was applied separately for
infants and children 1–4 years of age. In so doing we are assuming
that (i) the residency prevalence and (ii) the study-defined LRTI
prevalence in the target population was the same as for our study
population.
Incidence of ARI and LRTI in age group i per 100,000
population per year was estimated from the number of KHDSS
resident cases presenting to the government outpatient department
in 2003/04, and the mid-year (2003/04) KHDSS population, for
age group i =,12 months, 1–4 years and ,5 years. The resident
population of KHDSS in the age-strata 0–11 months and 1–4
years was estimated to be 8123 and 31 870, respectively, on 30th
October 2003. The incidence of RSV-LRTI cases was defined as
the incidence of LRTI multiplied by the proportion of the study
sample that was RSV positive.
RSV in Kenyan Children
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Results
Population Characteristics
Between May 1, 2002 and April 30, 2004, 27,555 child ,5yrs
visits were made to the outpatient department (Fig. 1); 11,866
(43%) visits were made by infants and 14,498 (53%) were made by
males. Of the total, 12,295 (45%) had a diagnosis of ARI (by
Government Clinical Officers or as identified by study field worker
based on a standard basic set of minimal symptoms) and were
eligible for recruitment, 140 (0.5%) had no diagnosis record. Of
those eligible 2262 (18%) were selected, 732 in 2002, 1101 in 2003
and 429 in 2004, and of these 99 (4%) either subsequently did not
have a diagnosis of ARI when reviewed by a research clinician or
had a missing diagnosis, and were excluded from further analysis.
The remaining 2163 children had a nasal wash sample taken and
tested for RSV antigen, but 20 (0.9%) children had a missing
laboratory result.
A comparison of the characteristics of the study population and
the target population is presented in Table 1. The proportion of
infants in the study population was higher than in the population
of children not selected for the study (44% vs 36%, P,0.0005), in
particular due to differences in children aged 6–11 months and 36
months and over. The proportion of ARI presentations classified
as LRTI within the study population of children (32%) was found
to be significantly higher than the proportion with LRTI in the
target populations (19%), even when adjusted for age (adjusted
OR=2.34 (2.10–2.60); P,0.001).
Epidemiology
Of the 2143 children who had an RSV test result, 166 (7.7%)
children were positive. RSV positivity was not significantly
associated with the sex of the child, even though there was
a higher proportion of cases who were boys in the age group 0–5
months (30% vs. 23%). The prevalence of RSV in children with
URTI was 6% (n= 80) and in children with LRTI it was 12%
(n= 86) (exact; P,0.001). Of all RSV-associated cases 45 (27%)
were aged 0–5 months and 36 (22%) were aged 6–11 months.
Parts of three RSV epidemics were observed with periods of
approximately 8 months between the first and second epidemic
and 15 months between the second and third epidemic. Seasonal
variation in RSV cases was generally synchronized with total
outpatient department presentations but was not temporally
related with any meteorological measure which was coincident
with inpatient population; where by the seasonal RSV pattern did
not coincide with any obvious climatic signal.
Clinical Characteristics
Of the 166 RSV-positive outpatient presentations in the study
population, 113 (68.1%) had an URTI; 26 (15.7%) had LRTI, and
27 (16.3%) had severe LRTI. None of these children was referred
for admission. LRTI was diagnosed in 23% of children under 5
years of age and in 20% of infants, of which an estimated 11% and
15%, respectively, were associated with an RSV infection. The
distribution of RSV-associated LRTI by age and severity is
presented in Table 2. Among cases of RSV disease the severity of
the clinical spectrum declined with age: URTI was observed more
commonly with increasing age and severe LRTI less commonly
(29% in children ,6 month to 8% in children 24 months of age
and older).
The presenting signs of all enrolled ARI presentations are
summarized in Table 3. In the sample of children the most
frequent clinical findings were fever (38%) and crackles (27%)
cough (25%) and fast breathing for age (20%). As shown in the
Table, amongst those in which RSV was detected compared with
those in which it was not, there were significantly more cases with
crackles, nasal flaring, in-drawing, fast breathing for age and with
fever. We assessed the differences in signs of RSV bronchiolitis
(e.g. crackles, nasal flaring, wheezing) after stratifying on severity
indicated by the presence of in-drawing and oxygen saturation
(hypoxia) (Table 4). There were only 4 children with hypoxia who
were also RSV positive too few to test for interaction. The
interaction between in-drawing and crackles on RSV positive was
found to be significant. In children with in-drawing the proportion
with RSV infection was similar in children with crackles and those
without crackles but in children without in-drawing, the pro-
portion with RSV was almost double in those with crackles
compared to those without crackles. There was a less significant
interaction (although larger effect) between in-drawing and nasal
flaring. Concurrent malaria parasitaemia and a clinical diagnosis
Figure 1. Flow diagram of recruitment and sample testing of
children aged under 5 years presenting to Kilifi District
Hospital from May 2002 to April 2004.
doi:10.1371/journal.pone.0052520.g001
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of malaria were both significantly less common among RSV-
positive children.
Incidence of OPD Attendance
The population of some 240,000 individuals has been under
demographic surveillance from year 2000 as part of the KHDSS.
Over the 1 year period between May 2003 and April 2004 for
which incidence was calculated, the number of outpatient cases
recruited was 1100 children 728 of whom were KHDSS residents
and 331 of these aged ,1 year. Of the 81 cases of RSV identified
during this period 50 cases were residents 23 of whom were
infants. Among the 331 outpatient infants resident in KHDSS 17
(5%) had a positive RSV test and an URTI and 6 (2%) had
a positive RSV test and a LRTI. Similarly, in resident children
under 5 years the prevalence of RSV in ARI cases was 6.9% (50/
728), in URTI cases was 5.2% (28/538) and in LRTI was 11.6%
(22/190). The estimated age-standardized population based
incidence of ARI in children ,1 year of age, 1–4 years of age
and ,5 years of age was 20473, 8867 and 11,172 cases per
100,000 population per year, respectively (Table 5). Correspond-
ingly, the LRTI incidence rates for children ,1 year of age, 1–4
years of age and ,5 years of age were 6185, 2010 and 2443 cases
per 100,000 per year, respectively. The population based in-
cidence rates for RSV-associated ARI were 1423, 603 and 767 per
100,000 per year for children aged ,1 year, 1–4 years and ,5
years, respectively. The incidence per 100,000 of RSV associated
LRTI in children aged ,1 year, 1–4 years and ,5 years was 557,
290 and 283 per year respectively.
Table 1. Characteristics of ARI Study Population.
Target Population Study Population Population Not Selected
P value(Fishers exact
test)
N Percent N Percent N Percent
Diagnosis of ARI
URTI 9948 80.9 1479 68.4 8469 83.6 ,0.0005
LRTI 2347 19.1 684 31.6 1663 16.4
sex
female 5919 48.2 1069 49.4 4850 47.9 0.195
male 6372 51.8 1094 50.6 5278 52.1
Diagnosis of malaria
no malaria 7682 62.5 1739 80.4 5943 58.7 ,0.0005
malaria 4613‘ 37.5 424* 19.6 4189 41.3
Age class of cases
,6 m 2505 20.4 490 22.6 2015 19.9 ,0.0005$
6–11 m 2079 16.9 469 21.7 1610 15.9
12–23 m 2903 23.6 549 25.4 2354 23.2
24–35 m 2037 16.6 321 14.9 1716 16.9
36–59 m 2771 22.5 334 15.4 2437 24.1
Infant
.365days 7711 62.7 1204 55.7 6507 64.2 ,0.0005
,= 365days 4584 37.3 959 44.3 3625 35.8
Notes.
*Diagnosis of malaria based on slide positivity.
‘Clinical diagnosis of malaria.
$Pearsons chi squared test comparing age in 5 strata.
doi:10.1371/journal.pone.0052520.t001
Table 2. Age-distribution of RSV associated LRTI OPD presentations to KDH stratified by severity category in the Study Population.
URTI LRTI Severe LRTI
Age class Positive % in age class Positive % in age class Positive % in age class Total Positive
,6 m 25 55.6 7 15.6 13 28.9 45
6–11 m 28 77.8 3 8.3 5 13.9 36
12–23 m 28 60.9 12 26.1 6 13.0 46
24–59 m 32 82.1 4 10.3 3 7.7 39
Total 113 68.1 26 15.7 27 16.3 166
doi:10.1371/journal.pone.0052520.t002
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Discussion
The features of symptomatic RSV infection in outpatient
presentations and denominator-based incidence estimates are
insufficiently described in sub-Saharan Africa. Our findings based
on surveillance of outpatient presentations at the rural district
hospital in Kilifi, Kenya over the period 2002 to 2004 provide an
assessment of the community health burden and clinical
characteristics of RSV cases attending an outpatient health
facility. The study estimates that RSV accounts for 7.7% of all
ARI presentations in children aged ,5 years. Furthermore, ARI
outpatient presentations account for 45% of presentations in the
under fives. These data demonstrate the considerable burden
contributed by ARI and RSV associated ARI to the health
resources.
Extrapolation from our sample to the hospital population yields
incidence estimates of RSV associated ARI of 1423 and 603 per
100,000 infants and children 1–4 years per year, respectively. The
corresponding incidence of LRTI attributable to RSV was 557
and 290 per 100,000 infants and children aged 1–4 years per year,
respectively. These estimates are substantially lower than reported
for a birth cohort in the same area [10,14]. In that study the
incidence of RSV associated ARI was 34,500 cases per 100,000
child years of observation (CYO) while the incidence of RSV-
LRTI cases was 9,000 and 10,400 per 100,000 CYO in all birth
cohort children (median age 25 months) and infants, respectively.
These two studies used the same case definitions and methods of
Table 3. Prevalence of clinical features in RSV positive and RSV negative children under 5 years of age presenting to OPD of Kilifi
District Hospital between May 2002 and April 2004.
Signs % RSV positive % RSV negative P RR$
n=166 n=1977
Clinical‘ crackles 42.2 25.2 ,0.001 1.63 (1.34–1.97)
wheezing 4.8 2.3 0.065 2.13 (1.01–4.50)
nasal flaring 6.6 2.3 0.003 2.66 (1.40–5.04)
indrawing 13.9 5.7 ,0.001 2.24 (1.47–3.40)
hypoxia 2.4 (165)* 2.4 (1938)* 1.000 1.00 (0.37 2.74)
fast breathing 26.8 (164) 19.2 (1963) 0.018 1.34 (1.03–1.75)
cough 33.7 24.7 0.008 1.42 (1.13–1.78)
fever (.37.5) 54.8 36.4 (1962)* ,0.001 1.54 (1.33–1.80)
Concurrent illness Slide positive 14.6 (75)* 34.4 (850)* ,0.001
Clinical diagnosis of malaria 10.2 20.4 0.001 0.55 (0.35–0.87)
Footnotes.
$MH RR risk adjusted for ageclass.
*Number of study participants included in this estimate.
‘prostration was very rare and is not included in the table.
doi:10.1371/journal.pone.0052520.t003
Table 4. Relationship between disease severity and clinical features in RSV positive and RSV negative children under 5 years of age
presenting to OPD of Kilifi District Hospital between May 2002 and April 2004.
Signs Indrawing No indrawing
% RSV
positive
n=23
% RSV
negative
n=113 RR P value
% RSV
positive
n=143
% RSV
negative
n=1864 RR P value Crude RR RR$
Clinical
ˆ
Crackles 78.3 73.5 1.07
(0.84–1.36)
0.6306
36.4 22.3 1.63
(1.29–2.06)
0.0001
1.67
(1.38–2.03)
1.45
(1.21–1.73)*
Wheezing 13.0 11.5 1.13
(0.35–3.66)
0.8346
3.5 1.8 1.97
(0.78–4.98)
0.1444
2.07
(0.99–4.31)
1.57
(0.76–3.22)
nasal flaring 30.4 27.4 1.11
(0.56–2.20)
0.7700
2.7 0.8 3.48
(1.17–10.34)
0.0177
2.85
(1.50–5.39
1.51
(0.86–2.65)
fast breathing 73.9 58.0 1.27
(0.95–1.70)
0.1555
19.1 16.8 1.14
(0.80–1.62)
0.4741
1.40
(1.07–1.83)
1.18
(0.92–1.52)
Footnotes.
$Adjusted for indrawing.
*Significantly different.
doi:10.1371/journal.pone.0052520.t004
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sample collection and RSV diagnosis. However, the higher
incidence estimates for the birth cohort study may be attributed
to the active case detection (weekly during RSV epidemics) in
place and enhanced self-referral to the study outpatient clinic
between active home visits for which free treatment and travel cost
was offered. The difference in incidence of ARI and RSV-
associated ARI identified between passive surveillance of the
present study and heightened case ascertainment of the birth
cohort, is illustrative of the true and frequently unrecognised
burden of RSV in the community.
One study from a tropical sub-Saharan African country,
Mozambique [27], carried out over the main months of a single
RSV epidemic (Feb-May 2000), reported a prevalence of RSV in
outpatient infants of 7% in those presenting with URTI and 10%
in those presenting with LRTI. These results accord well with the
findings from the present study, where the equivalent proportions
were 6% in infants with URTI and 12% in those with LRTI.
Comparatively, studies from industrialised countries suggest
a higher proportion of ARI outpatient department presentations
are RSV positive [12], which may well be attributable to ease of
access and differential health service utilisation behaviour.
One in every six of the RSV positive children presenting to the
KDH outpatient department had syndromically defined severe or
very severe LRTI. Although eligible for hospital admission
according to IMCI guidelines [28] none of the 27 cases were
referred for admission. A similar observation was reported in
a birth cohort study within the same population and reinforces the
warning that hospital data will under-estimate the burden of RSV
associated severe LRTI [10,14]. However, since the well trained
clinicians who reviewed these children did not consider them
sufficiently unwell to refer for admission the result supports the
assertion of definitions which have low specificity for LRTI [29]
RSV associated disease in outpatient presentations appears to
share similar features typical of those RSV cases seen in the
hospital in-patient wards. The clinical signs crackles, nasal flaring,
fast breathing, fever and lower chest-wall in-drawing were all
associated with RSV similar to reports of the inpatient cases from
the same population [15] as in other populations [27]. These signs
were present at a lower percentage than those in a study from
Mozambique [27]. Almost half of the outpatients with RSV
associated ARI had crackles and were febrile and a higher
proportion of RSV cases relative to those without a diagnosis of
RSV were associated with more severe disease (16.3% vs 7.7%).
Stratification on severity indicated that RSV infection in non-
severe cases (without in-drawing) was associated with increased
incidence of crackles and nasal flaring. The prevalence of malaria
(clinical and slide confirmed) was lower in those children with an
RSV infection in this study population than in those children
without an RSV infection.
While RSV associated severe LRTI in outpatient cases was, like
IP cases [15], most common in early infants (,6 m of age), overall
there were as many cases in children aged one year and over as in
infants. Clearly, maternal vaccination to boost infant passive
immunity or vaccination to directly protect early infants would be
beneficial in preventing the most severe RSV. However, delayed
vaccination to the second 6months of life where immunogeniocity
and tolerance are much improved would potentially have high
benefit by preventing much of outpatient RSV burden.
There are some limitations to our study. First, passive
surveillance at health facilities that depend mainly on the study
population actually using hospitals or health centres may
contribute to difference between these and other studies. Incidence
rates for admissions were double in the region immediately
surrounding the hospital [15] which would suggest that individuals
may opt to go to Health Facilities closer to their places of
residence. While Kilifi District Hospital is the main admitting
facility in the KHDSS, there are several Health centres that
patients can visit to access outpatient care. This implies that the
catchment populations for outpatient services versus inpatient
services may not be comparable. Secondly, there is reduced
sensitive of case surveillance because of the viral detection method
used. Using RT-PCR methods and serologic examination affords
greater sensitivity [14,30,31,32]. However it important to note that
these are not routinely available in resource limited settings.
Thirdly, it has been reported that HIV has some influence on the
RSV infection [33]. This study did not investigate the influence of
HIV on the study population thus the influence of HIV as
a confounder is not precisely known. However, the overall HIV-1
prevalence in women attending to KDH antenatal care in 2004
was 4.8% (95% CI 3.4–6.6) [17]. Lastly, only a sub sample of
outpatient presentations were included which is not optimal.
Several adjustments were undertaken to account for this. Mainly
in order to standardise LRTI diagnosis for the purpose of
incidence estimation, the prevalence of LRTI in the KDH
outpatient department population was imputed using the study
LRTI diagnosis. The assumption is that the diagnosis of LRTI in
the study (based on WHO criteria) is more standard and reliable
than that in the KDH outpatient department. The different
diagnostic criteria of ARI applied within the study and by
Government clinicians could potential influence our results.
However, because we wanted to capture all respiratory infections
we used minimal symptoms to define a respiratory infection in the
study population. No adjustment was done for ARI because we do
not think there was any ambiguity about the diagnosis of an ARI
in this population. Additionally, overall incidence estimates of
LRTI and RSV-LRTI for children aged ,5 years were adjusted
for the differences in infant population between the study sample
and the KDH outpatient department presentations. Importantly,
as described recruitment was done in a random manner and
a comparison between the whole population and of the sample
indicates that the characteristics were largely similar. Nevertheless
it is acknowledged that the study sample may not be truly
representative of the population as a whole.
The burden of RSV in Africa is not fully appreciated by most
public health officials given that RSV, albeit an important culprit
[10,34,35], is not the only cause of pneumonia in African children
and is not as widely exposed and more specifically because it is
only one of countless other pathogens that characteristically cause
respiratory disease in African children. These data are useful
principally because one, as the data show not all serious cases get
to hospital; an issue that is of particular concern in developing
countries where a minority of cases actually make it to hospital
[14,36] and two because in general, inpatient hospital studies
Table 5. Estimated age-standardized population based
incidence of ARI in children per 100,000 population per year.
ARI LRTI RSV-ARI RSV-LRTI
,1 year 20,473
(19,523–21,469)
6,185
(5,635–6,789)
1,423
(1,186–1,707)
557
(408–759)
1–4 years 8,867
(8,550–9,296)
2,010
(1,872–2,159)
603
(525–692)
290
(240–350)
,5 years 11,172
(10,854–11,499)
2,443
(2,308–2,588)
767
(653–901)
283
(254–316)
doi:10.1371/journal.pone.0052520.t005
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ignore the individually less serious, but still important, disease
burden in the community. In summary, this is one of few studies of
RSV in outpatient populations in Africa. On the basis of our
findings we estimate that in children less than 5 years RSV
infection results in approximately 3% of all outpatient presenta-
tions and 8% of all presentation with a diagnosis of ARI. In
comparison, a clinical diagnosis of malaria is made in 36% of all
sick child visits roughly half of which will be true malaria events
based on a positive blood film. However, infection with RSV was
associated with more severe disease thus its contribution to disease
is significant.
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